Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: Comment on the article by Smolen et al [1] (multiple letters)

Arthritis and Rheumatism

Volumn 52, Issue 12, 2005, Pages 4044-4045

  Pincus, Theodore ^a   Yazici, Yusuf ^b   Yazici, Hasan ^c   Kavanaugh, Arthur F ^d   Kremer, Joel M ^e   Wolfe, Frederick ^f   Smolen, Josef S ^g   Maini, Ravinder N ^h   Han, Chenglong ⁱ   Baker, Daniel ⁱ   Lipsky, Peter L ^j  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

^c ISTANBUL UNIVERSITY   (Turkey)

^d Center for Innovative Technololgies   (United States)

^e Center for Rheumatology LLP   (United States)

^f National Databank for Rheumatic Diseases   (United States)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ CENTOCOR INC   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; INFLIXIMAB; INTERLEUKIN 1; METHOTREXATE; PLACEBO; TUMOR NECROSIS FACTOR ANTIBODY;

AREA UNDER THE CURVE; CLINICAL FEATURE; DEMOGRAPHY; HUMAN; INFLAMMATION; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TRANSGENIC MOUSE;

EID: 29144500424     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21430     Document Type: Letter

References (0)